The role of neuropsychological evaluation in pediatric sickle cell disease

Brian Daly1, Mary C Kral, Reem A Tarazi

  • 1Department of Psychology, Drexel University, Philadelphia, PA 19146, USA. brian.daly@drexel.edu

Insights

Children with sickle cell disease (SCD) experience neuropsychological impairments. This study recommends an informed approach to neuropsychological evaluation for youth with SCD, considering illness factors and developmental stage.

Area of Science:

  • Pediatric Neurology
  • Neuropsychology
  • Hematology

Background:

  • Children and adolescents with sickle cell disease (SCD) frequently experience neuropsychological impairment.
  • Existing research identifies sequelae linked to cerebrovascular disease but lacks a defined clinical approach for neuropsychological evaluation in this population.
  • The standard of care and transition to adulthood for youth with SCD, impacting long-term outcomes, remain understudied.

Purpose of the Study:

  • To delineate a well-informed clinical approach to neuropsychological evaluation for children and adolescents with sickle cell disease.
  • To provide recommendations for evaluating neuropsychological outcomes in youth with SCD.
  • To offer a model for other pediatric populations facing similar challenges.

Main Methods:

  • The study provides recommendations based on pertinent illness-related factors.
  • Consideration of general developmental level and timing of evaluation (baseline vs. follow-up) is emphasized.
  • The relationship to medical treatment and the transition to adulthood are key factors in the proposed approach.

Main Results:

  • Recommendations are presented for an informed neuropsychological evaluation approach tailored to youth with sickle cell disease.
  • The approach integrates illness-specific factors, developmental stage, and treatment context.
  • The proposed framework aims to guide comprehensive assessment and care.

Conclusions:

  • A structured, empirically informed approach to neuropsychological evaluation is crucial for children and adolescents with sickle cell disease.
  • This approach should consider individual illness factors, developmental trajectory, and the critical transition to adulthood.
  • The recommended methodology can serve as a valuable model for assessing other pediatric conditions with potential neuropsychological impact.